LOX-1 receptor-targeted peptide-based PET imaging agent (AstraZeneca/University of Virginia)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameLOX-1 receptor-targeted peptide-based PET imaging agent (AstraZeneca/University of Virginia)
Drug Alias NameN/A
ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionLDL receptor modulators
TargetsLDL receptor
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Virginia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca PlcUniversity Of Virginia
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A